Leucoflex CGP
Anticoagulant Citrate Phosphate Dextrose Solution USP (CPD)With an Integral Container of Additive Solution (AS-1) Preservative,And an Integral Leucoflex CGP Leukocyte Reduction Filter for Red Blood Cells
Approved
Approval ID
6df66dde-e9ae-414a-afff-6073bed561e3
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Dec 5, 2019
Manufacturers
FDA
Maco Productions
DUNS: 265492868
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Anticoagulant Citrate Phosphate Dextrose Solution with Additive Solution AS-1
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code14498-002
Application NumberBN040083
Product Classification
M
Marketing Category
C73594
G
Generic Name
Anticoagulant Citrate Phosphate Dextrose Solution with Additive Solution AS-1
Product Specifications
Effective DateJanuary 30, 2017
FDA Product Classification